She Lok

789 total citations
16 papers, 596 citations indexed

About

She Lok is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, She Lok has authored 16 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in She Lok's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Eosinophilic Disorders and Syndromes (4 papers) and Viral-associated cancers and disorders (4 papers). She Lok is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Eosinophilic Disorders and Syndromes (4 papers) and Viral-associated cancers and disorders (4 papers). She Lok collaborates with scholars based in United Kingdom, Australia and Ireland. She Lok's co-authors include Jim Egan, James P. Stewart, B. Kelly, P S Hasleton, Ashley Woodcock, Robert J.O. Davies, Alan J. Ross, Christopher W.H. Davies, J. Egan and Nizar Yonan and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and European Respiratory Journal.

In The Last Decade

She Lok

15 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
She Lok United Kingdom	11	441	168	120	108	89	16	596
Patricio Luburich Spain	16	326 0.7×	111 0.7×	73 0.6×	97 0.9×	88 1.0×	38	553
Daniele Bendayan Israel	16	405 0.9×	154 0.9×	186 1.6×	49 0.5×	41 0.5×	23	718
P. Latsi Greece	13	1.2k 2.6×	170 1.0×	100 0.8×	59 0.5×	85 1.0×	23	1.3k
Kazumasa Yasuda Japan	13	549 1.2×	512 3.0×	115 1.0×	93 0.9×	231 2.6×	38	940
Jason S. Vourlekis United States	9	1.0k 2.3×	137 0.8×	69 0.6×	26 0.2×	72 0.8×	12	1.1k
Andrew L. Chan United States	14	482 1.1×	79 0.5×	78 0.7×	24 0.2×	35 0.4×	20	577
Nicola Lanzarone Italy	13	268 0.6×	64 0.4×	71 0.6×	31 0.3×	29 0.3×	19	417
Hirotsugu Hasegawa Japan	12	379 0.9×	57 0.3×	29 0.2×	55 0.5×	26 0.3×	35	501
Sameep Sehgal United States	11	182 0.4×	38 0.2×	73 0.6×	52 0.5×	28 0.3×	27	339
Ramakant Dixit India	14	203 0.5×	95 0.6×	213 1.8×	66 0.6×	26 0.3×	80	486

Countries citing papers authored by She Lok

Since Specialization

Citations

This map shows the geographic impact of She Lok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by She Lok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites She Lok more than expected).

Fields of papers citing papers by She Lok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by She Lok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by She Lok. The network helps show where She Lok may publish in the future.

Co-authorship network of co-authors of She Lok

This figure shows the co-authorship network connecting the top 25 collaborators of She Lok. A scholar is included among the top collaborators of She Lok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with She Lok. She Lok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lok, She, et al.. (2025). Paradoxical Embolism Through Patent Foramen Ovale: A Case Report of Thrombus in Transit. American Journal of Case Reports. 26. e946997–e946997.

Kendrick, Elizabeth, et al.. (2022). A Covid -19 Virtual Ward Model: A Preliminary Retrospective Clinical Evaluation From a UK District General Hospital. Journal of Primary Care & Community Health. 13. 4257686827–4257686827. 17 indexed citations

Nadeem, Iftikhar, et al.. (2021). Role of Advanced Respiratory Support in Acute Respiratory Failure in Clinically Frail Patients with COVID-19. Future Microbiology. 17(2). 89–97. 3 indexed citations

Nadeem, Iftikhar, et al.. (2021). Relationship of D-Dimer and Prediction of Pulmonary Embolism in Hospitalized COVID-19 Patients: A Multicenter Study. Future Microbiology. 16(12). 863–870. 5 indexed citations

Newman, Joseph, et al.. (2021). Images of the month 1: ‘Soy sauce’ pleural effusion: what causes black pleural fluid?. Clinical Medicine. 21(5). e531–e532. 2 indexed citations

Chong, Kelvin Kian Long, et al.. (2011). Spontaneous haemopneumothorax. BMJ Case Reports. 2011. bcr0420114065–bcr0420114065. 3 indexed citations

Egan, Jim, Huzaifa Adamali, She Lok, James P. Stewart, & Ashley Woodcock. (2011). Ganciclovir Antiviral Therapy in Advanced Idiopathic Pulmonary Fibrosis: An Open Pilot Study. Pulmonary Medicine. 2011. 1–5. 27 indexed citations

Kelly, B., She Lok, P S Hasleton, Jim Egan, & James P. Stewart. (2002). A Rearranged Form of Epstein–Barr Virus DNA Is Associated with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 166(4). 510–513. 104 indexed citations

Lok, She, et al.. (2002). Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. European Respiratory Journal. 20(5). 1228–1232. 63 indexed citations

10.

Lok, She, James P. Stewart, B. Kelly, P S Hasleton, & J. Egan. (2001). Epstein–Barr virus and wild p53 in idiopathic pulmonary fibrosis. Respiratory Medicine. 95(10). 787–791. 27 indexed citations

11.

Lok, She & J. Egan. (2000). Viruses and idiopathic pulmonary fibrosis.. PubMed. 55(2). 146–50. 18 indexed citations

12.

Stewart, James P., Jim Egan, Alan J. Ross, et al.. (1999). The Detection of Epstein-Barr Virus DNA in Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 159(4). 1336–1341. 158 indexed citations

13.

Lok, She. (1999). Interstitial lung disease clinics for the management of idiopathic pulmonary fibrosis: a potential advantage to patients. The Journal of Heart and Lung Transplantation. 18(9). 884–890. 18 indexed citations

14.

Davies, Christopher W.H., She Lok, & Robert J.O. Davies. (1998). The Systemic Fibrinolytic Activity of Intrapleural Streptokinase. American Journal of Respiratory and Critical Care Medicine. 157(1). 328–330. 69 indexed citations

15.

Lok, She, Elaine Smith, Helen Doran, et al.. (1998). Idiopathic Pulmonary Fibrosis and Cyclosporine. CHEST Journal. 114(5). 1478–1481. 16 indexed citations

16.

Egan, Jim, Lisa G. Barber, She Lok, et al.. (1998). PREEMPTIVE TREATMENT FOR THE PREVENTION OF CYTOMEGALOVIRUS DISEASE. Transplantation. 65(5). 747–752. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact